home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> mail archive   |   Search register for news alert (free)  
  Carlo Gambacorti: DIAG: 7 messages (2 PT. REQ.)  
   

archive of HUM-MOLGEN mails

 
 

[Author Prev][Author Next][Thread Prev][Thread Next][Author Index][Topic Index]

To: Multiple recipients of list HUM-MOLGEN <HUM-MOLGEN@NIC.SURFNET.NL>
Subject: DIAG: 7 messages (2 PT. REQ.)
From: Carlo Gambacorti <GAMBACORTI@ICIL64.CILEA.IT>
Date: Wed, 21 Feb 1996 09:52:08 +0000

**************************************************************
           HUM-MOLGEN  DIAGnostics/Clinical Research
**************************************************************


This DIAG message contains 7 submessage(s):

1)        Genetic approaches to pain

2)        diagnosis of Smith-Lemli-Opitz syndrome

3)        Iduronate sulphatase deficiency

4)        BOWENOID HPV/ PT. REQ.

5)        Meckel-Gruber/ PT. REQ.

6)        Ataxia and retinitis pigmentosa

7)        Klippel-Feil syndrome


  Carlo Gambacorti MD, Editor,
  Human Molecular Genetics network
  Diagnostics/Clinical Research Section

**************************************************************
**************************************************************


We would like to contact groups working on the genetics of congenital
insensitivity to pain - dysautonomias or other syndromes. If you are there,
please contact me on ucgajwo@ucl.ac.uk.
Thankyou.

John N. Wood Ph.D.
Medawar Building Room A2
Department of Anatomy and Developmental Biology,
University College,
Gower Street,
London WC1E 6BT
England             tel/FAX 44-0171-380-7800
**************************************************************

Dear Colleague,

We are using measurements of 7-dehydro-cholesterol to confirm our clinical
diagnoses of Smith-Lemli-Opitz syndrome. We have been reassured that our
clinical diagnoses have been confirmed by the laboratory test, and have used
these studies for prenatal diagnosis.

We are concerned that we may be failing to test children who have
abnormalities of cholesterol metabolism and relatively mild or non-specific
clinical features. We would be interested in your experience. How wide is
the spectrum of phenotypic abnormalities in children with abnormal 7DHC
measurements? What criteria do you use in deciding which children to test?
Should we be testing all babies with non-specific dysmorphic features and
moderate developmental delay?

I would value your comments.

Yours sincerely,

Graeme Suthers.
________________________________________________________________________
Dr Graeme Suthers
SA Clinical Genetics Service
Centre for Medical Genetics
Women's & Children's Hospital
North Adelaide SA 5006
AUSTRALIA

tel  (08) 204 7375 (International prefix -61-8-)
fax  (08) 204 6088 (International prefix -61-8-)
email      suthersg@wch.sa.gov.au (Using MSmail)
>> Please note new email address <<

**************************************************************

Dear Sir/Madam:
                I have received a request from a family in Argentina that has a
young boy that has been diagnosed with a mucopolyssacharidosis, most likely
iduronate 2 sulphatase deficiency. Can you please let me know if there is any
new treatment available and lab. test to confirm the diagnosis?. They are havin
ga hard time getting current information on possible treatment and specialists
due to the rarity of the dissease.
                                        Sincerely
                                        Dr. Gabriela Dveksler
                                Dveksler@USUHSB.USUHS.MIL
**************************************************************

PRESENTING MY PLEA FOR ANY INFORMATION.
>>I HAVE HAD WIDESPREAD BOENOID/HPV INFECTION OF LOWER GENITAL
TRACT, PERINEUM, PERI-ANAL REGION AND NATAL CLEFT AND MULTIFOCAL
INTRAEPITHELIAL NEOPLASIA OF THE LOWER GENITAL TRACT, NAMELY
CERVIX, ANTERIOR VULVA, PERINEUM AND NATAL CLEFT.
>>THESE AREAS WHERE ATTENDED TO WITH EXTENSIVE SURGERY.
I AM INTERESTED IN ANY EXPERIMENTAL
GENETIC/IMMUNOLOGIC/PHARMACOLOGIC TREATMENT FOR MY DISEASE.
>>PLEASE, PLEASE ANY INFORMATION URGENT.
>>DOB 31/01/1960
>>FEMALE
Apparent patient location: Australia

     *** PLEASE, REPLY TO HUMAN MOLECULAR GENETICS DIRECTLY ***

**************************************************************

I have recently had 2 pregnancies result in very unhealthy babies which did
not survive.  The autopsy findings suggest the possibility of Meckel-Gruber
syndrome, hover it is not a clinical case of Meckel.  I am desperatly looking
for more research on Meckel/ more opions on wether this diagnose could be
more accurate.  Please help me or guide me in another direction.  I am
desperate to know as much as I possibly can.
                                                    Gratefully,

Apparent patient location: USA

     *** PLEASE, REPLY TO HUMAN MOLECULAR GENETICS DIRECTLY ***

**************************************************************
>
>  Dear Colleague:
>
>
>  Some months ago I was challenged by a family with a distinct autosomal
> dominant cerebellar ataxia associated with visual failure secondary to
> retinal pigmentary changes. Ages of onset and clinical course were
> variable(visual failure was not a feature in some patients of this family),
> but ataxia was a constant feature. Transmission of the disease to severe,
> infantile-onset cases occured in two siblings and both had a severe course,
> dying during adolescence.The ophthalmological examination always disclosed
> retinitis pigmentosa in those who are  blind.
>
> Almost all of the affected  adult patients in this family have already
> died. One affected young lady is living in the US but I do not know
> specifically  where she is receiving medical care. One affected male living
> in Rio de Janeiro, now aged 27 is completely blind and has hyperactive
> tendon reflexes and some other  severe neurological features besides
> ataxia.His intellect is apparently normal. His mother was  blind and ataxic
> and died from the progressive disease about two years ago. Two married  and
> apparently "healthy" brothers at ages 32 and 35 want desperately a
> presymptomatic diagnosis since they are planning to have children.
>
>  I searched the literature and found a report from Enevoldson et al (Brain
> 117:445-60, 1994)  on 54 members of eight families in England, who
> presented with  features similar to those here described. As far as I know,
> the gene mutation of this type  of ataxia and blindness is still unknown
> and there is a possibility that like other types, it may consist of an
> unstable trinucleotide repeat expansion.The report of Gouw et al.
> (Neurology, 44:1441-7, 1994 is also pertinent and they have done linkage
> analysis to both SCA1 and SCA2.
>
>  We plan to report this family as soon as possible.I would value comments
> of anyone with some clinical and genetic experience with a similar
> family.Would anyone  doing research in the area of molecular neurogenetics
> be interested in getting a blood sample from the above mentioned patient
> with the purpose of studying the gene mutation?
>
>
>  If someone is interested please contact me.
>
>  Sincerely,
>
>  Gerson Carakushansky, M.D.
>  Federal University of Rio de Janeiro
>  Instituto de Pediatria Martagao Gesteira da UFRJ
>  Genetica
>  Rio de Janeiro  21941-590 - Brazil
>  FAX: (5521)227-3441
>  E-mail: gercar@unisys.com.br

**************************************************************

We have been studying a number of families with skeletal and spinal defects.
We wish to identify parties interested in collaborating in identifying genes inv
olved in the Klippel-Feil syndrome,
Slipped capital epiphysis and hemivertebrae

R.Clarke@unsw.edu.au (Raymond Clarke) sent the following comments:

**************************************************************



   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Mail converted by MHonArc 2.4.4
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2001 HUM-MOLGEN. All rights reserved. Liability and Copyright.